Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban.
Health Technology Assessment Unit, ESTAV Toscana Centro, Regional Health Service, 50100, Firenze, Italy, andrea.messori.it@gmail.com.
Andrea
A
Messori
Dario
D
Maratea
Valeria
V
Fadda
Sabrina
S
Trippoli
D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*
D000925:Anticoagulants